These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3855174)

  • 1. Sarcoidosis is not associated with the HTLV III virus.
    Flint KC; Hudspith BN; Chiensong-Popou R; Tedder R; James DG; Johnson NM
    Sarcoidosis; 1985 Sep; 2(2):157. PubMed ID: 3855174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunological profile of drug addicts: HTLV-III negative, HTLV-III positive and those with lymphadenopathy syndrome-AIDS related complex].
    Cascavilla N; Martini E; Melillo L; Musto P; Nobile M; Valori VM; Di Giorgio G; Carotenuto M
    Recenti Prog Med; 1987 Mar; 78(3):108-12. PubMed ID: 3648856
    [No Abstract]   [Full Text] [Related]  

  • 3. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of HTLV-III/LAV antibody in selected populations in Thailand.
    Wangroongsarb Y; Weniger BG; Wasi C; Traisupa A; Kunasol P; Rojanapithayakorn W; Fucharoen S
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):517-20. PubMed ID: 3869739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of radioimmunoassay with enzyme immunoassay in the detection of serum antibodies against the human immunodeficiency virus].
    Abad MA; Leal M; Pineda JA; Velardo MA; Muñoz J; Pascual A; García de Pesquera F; Lissen E
    Med Clin (Barc); 1987 Jun; 89(4):144-6. PubMed ID: 3306190
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
    Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
    Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and epidemiological features of primate lymphotropic retroviruses.
    Hunsmann G; Schneider J; Bayer H; Jurkiewicz E; Yamamoto N
    Princess Takamatsu Symp; 1984; 15():109-18. PubMed ID: 6100632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTLV and immunosuppression.
    Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
    Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on antibody surveillance to EB virus-induced antigen in patients with sarcoidosis and nasopharyngeal carcinoma by indirect immunofluorescence.
    Naito M; Akiyama Y; Kato S; Tachibana T; Sakai T
    Biken J; 1973 Dec; 16(4):141-8. PubMed ID: 4363326
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serological survey on the prevalence of anti-HTLV-III antibodies in a psychiatric hospital].
    Antila CC; Blotta MH; Gomes MC
    Rev Paul Med; 1986; 104(6):328. PubMed ID: 3650926
    [No Abstract]   [Full Text] [Related]  

  • 11. [The HTL IV virus: a new human retrovirus without pathogen protection against the HTLV III/LAV virus?].
    Mboup S; Essex M; Kank P; Ndoye I; Barin F; Samba ; Boye CS; Ricard D; Denis F; Romet JL
    Afr J Sex Transmi Dis; 1986 Oct; 2(2):81-4. PubMed ID: 12281131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-HTLV III antibodies in the personnel of a hospital in the Campania region].
    Ferro V; Sapia P; Perna C; Salvi MP; Piscopo V
    Quad Sclavo Diagn; 1986 Mar; 22(1):104-9. PubMed ID: 3641325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of human T-lymphotrophic virus type I in patients with systemic lupus erythematosus.
    Lipka K; Tebbe B; Finckh U; Rolfs A
    Clin Exp Dermatol; 1996 Jan; 21(1):38-42. PubMed ID: 8689767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal study of HTLV-III-infected chimpanzees by lymphocyte subpopulation analysis.
    Eichberg JW; Alter HJ; Dreesman GR
    J Med Primatol; 1985; 14(6):317-26. PubMed ID: 3878410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-III antibodies in a patient with mycosis fungoides.
    Srivastava BI; Getchell JP; Stoll HL
    J Med; 1986; 17(1):57-63. PubMed ID: 3473157
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevalence of anti-HTLV-III antibodies in volunteer blood donors in Guipuzcoa].
    Cortés A; Francisco C; Larrañaga MJ; Cárdenas JM
    Med Clin (Barc); 1987 Jan; 88(1):38-9. PubMed ID: 3644127
    [No Abstract]   [Full Text] [Related]  

  • 17. Adult T-cell leukemia/lymphoma in Jamaica and its relationship to human T-cell leukemia/lymphoma virus type I-associated lymphoproliferative disease.
    Gibbs WN; Lofters WS; Campbell M; Hanchard B; LaGrenade L; Clark J; Cranston B; Saxinger C; Gallo R; Blattner WA
    Princess Takamatsu Symp; 1984; 15():77-90. PubMed ID: 6100652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential diagnosis of lymphadenopathy in HIV/AIDS].
    Pivnik AV; Korovushkin VG; Parkhomenko VN; Tonkoglaz VN; Pavlova LE; Litivinova NG; Peregudova AB; Degterev DA; Gruzdev BM
    Ter Arkh; 2006; 78(4):28-32. PubMed ID: 16821418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic abnormalities and antibodies to HTLV-III in asymptomatic drug addicts.
    Ortona L; Laghi V; Tamburrini E; Nervo P; Cauda R
    Ala J Med Sci; 1987 Jan; 24(1):46-51. PubMed ID: 3644604
    [No Abstract]   [Full Text] [Related]  

  • 20. Computerised anti-HTLV-III data collection and integration.
    Houston SR; Barr A
    Med Lab Sci; 1986 Oct; 43(4):340-3. PubMed ID: 3477676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.